CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($) $ in Thousands		Common Stock	Additional Paid-in Capital Adjustment	Additional Paid-in Capital	Accumulated Deficit Adjustment	Accumulated Deficit	Adjustment	Total
Beginning balance (ASU 2020-06) at Dec. 31, 2023			$ (393)		$ 224		$ (169)
Beginning balance at Dec. 31, 2023		$ 73		$ 415,045		$ (381,549)		$ 33,569
Beginning balance (in shares) at Dec. 31, 2023	[1]	72,952,124
Share-based compensation related to stock options				500				500
Share-based compensation related to restricted stock awards				481				481
Share-based compensation related to restricted stock awards (in shares)	[1]	100,000
Net Income (Loss)						(4,595)		(4,595)
Ending balance at Mar. 31, 2024		$ 73		415,633		(385,920)		29,786
Ending balance (in shares) at Mar. 31, 2024	[1]	73,052,124
Beginning balance at Dec. 31, 2024		$ 76		421,528		(378,393)		43,211
Beginning balance (in shares) at Dec. 31, 2024	[1]	75,850,275
Issuance of common stock under the Sales Agreement, net		$ 1		2,860				2,861
Issuance of common stock under the Sales Agreement, net (in shares)	[1]	1,325,179
Share-based compensation related to stock options				336				336
Share-based compensation related to restricted stock awards				204				204
Exercise of warrants and options		$ 1		2,214				2,215
Exercise of warrants and options (in shares)	[1]	958,375
Net Income (Loss)						(3,619)		(3,619)
Ending balance at Mar. 31, 2025		$ 78		$ 427,142		$ (382,012)		$ 45,208
Ending balance (in shares) at Mar. 31, 2025	[1]	78,133,829

[1] Common stock, $0.001 par value; Authorized – as of March 31, 2025 and December 31, 2024 – 185,000,000 shares.